<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">24137279</PMID>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1792-0981</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>6</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2013</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Experimental and therapeutic medicine</Title>
                <ISOAbbreviation>Exp Ther Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>863-867</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Contrast-induced nephropathy (CIN) is a complex syndrome of acute kidney injury that follows exposure to intravascular contrast media. Although a series of preventive measures have been developed, CIN remains a major challenge encountered in elderly patients by interventional cardiologists. No data are currently available concerning the potential effects of the combined use of hydration and alprostadil in the prevention of CIN following percutaneous coronary intervention (PCI) in elderly patients. Therefore, the aim of the present study was to investigate the ability of a combination of hydration and alprostadil to prevent CIN following PCI in elderly patients. From June 1, 2010 to January 31, 2012, 85 elderly patients undergoing PCI were included in the present study. The included patients were randomly allocated into three groups: the control (22 cases), hydration (28 cases) and hydration + alprostadil (35 cases) group. Serum creatinine (SCr) levels were measured prior to PCI and then daily for 3 days following PCI. Creatinine clearance (Ccr) was also calculated. Following investigation of the incidence of CIN, a significant decline in Ccr was observed in the control group but not in the hydration + alprostadil group after PCI. The reduction in the level of Ccr from baseline in the hydration + alprostadil group was the smallest among the three groups. Moreover, the highest incidence of CIN was in the control group (6 cases, 27.27%), followed by the hydration group (3 cases, 10.71%) and the hydration + alprostadil group (1 case, 2.86%). Therefore, the combined use of hydration and alprostadil significantly reduces the incidence of CIN in elderly patients undergoing PCI. Hydration and alprostadil are suggested to act synergistically to protect renal function. In conclusion, the combined use of hydration and alprostadil is more effective in the prevention of CIN in elderly patients undergoing PCI compared with hydration alone.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Rong-He</ForeName>
                    <Initials>RH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, Affiliated Shantou Hospital of Sun Yat-sen University, Shantou, Guangdong 515031, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Gui-Zhou</ForeName>
                    <Initials>GZ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cai</LastName>
                    <ForeName>Zhi-Xiong</ForeName>
                    <Initials>ZX</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Ping</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Zhi-Dan</ForeName>
                    <Initials>ZD</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Wen-Liang</ForeName>
                    <Initials>WL</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Greece</Country>
            <MedlineTA>Exp Ther Med</MedlineTA>
            <NlmUniqueID>101531947</NlmUniqueID>
            <ISSNLinking>1792-0981</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">alprostadil</Keyword>
            <Keyword MajorTopicYN="N">contrast-induced nephropathy</Keyword>
            <Keyword MajorTopicYN="N">elderly patient</Keyword>
            <Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>04</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2013</Year>
                <Month>07</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">24137279</ArticleId>
            <ArticleId IdType="doi">10.3892/etm.2013.1258</ArticleId>
            <ArticleId IdType="pii">etm-06-04-0863</ArticleId>
            <ArticleId IdType="pmc">PMC3797303</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>Am J Ther. 2001 May-Jun;8(3):155-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11344383</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2009 Feb 3;150(3):170-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19189906</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2005 Feb;20 Suppl 1:i18-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15705944</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prostaglandins Leukot Essent Fatty Acids. 2006 Dec;75(6):403-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17011760</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 2006 Feb 21;113(7):e166-286</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16490830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJR Am J Roentgenol. 2004 Dec;183(6):1673-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15547209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 2004 Nov 2;44(9):1763-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15519005</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 2006 May 16;47(10):2130-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16697342</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephron. 1976;16(1):31-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1244564</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int Suppl. 2006 Apr;(100):S11-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16612394</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 2008 Apr 15;51(15):1419-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18402894</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circulation. 1990 Dec;82(6):2231-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2242544</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Radiology. 1997 Jun;203(3):605-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9169676</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tohoku J Exp Med. 2010 Jul;221(3):211-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20551600</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2000 Jan;15(1):43-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10607766</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Nephrol Renovasc Dis. 2011;4:85-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21912486</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>